SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Vahlquist Anders)
 

Search: WFRF:(Vahlquist Anders) > (2000-2009) > Characterization of...

Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines : trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition

Chamcheu, Jean Christopher (author)
Uppsala universitet,Dermatologi och venereologi,Dermatology and Venereology
Lorié, Elizabeth Pavez (author)
Uppsala universitet,Dermatologi och venereologi,Dermatologi och venereologi, Dermatology and Venereology
Akgul, Baki (author)
Centre for Cutaneous Research, ICMS, Bart's and London Queen Mary's School of Medicine and Dentistry, London, United Kingdom
show more...
Bannbers, Elin (author)
Uppsala universitet,Dermatologi och venereologi
Virtanen, Marie (author)
Uppsala universitet,Dermatologi och venereologi,Dermatology and Venereology
Gammon, Luke (author)
Centre for Cutaneous Research, ICMS, Bart's and London Queen Mary's School of Medicine and Dentistry, London, United Kingdom
Moustakas, Aristidis (author)
Uppsala universitet,Ludwiginstitutet för cancerforskning
Navsaria, Harshad (author)
Centre for Cutaneous Research, ICMS, Bart's and London Queen Mary's School of Medicine and Dentistry, London, United Kingdom
Vahlquist, Anders (author)
Uppsala universitet,Dermatologi och venereologi,Dermatology and Venereology
Törmä, Hans (author)
Uppsala universitet,Dermatologi och venereologi,Dermatology and Venereology
show less...
 (creator_code:org_t)
Elsevier, 2009
2009
English.
In: Journal of dermatological science (Amsterdam). - : Elsevier. - 0923-1811 .- 1873-569X. ; 53:3, s. 198-206
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND: Epidermolysis bullosa simplex (EBS) is an autosomal inherited mechano-bullous disease, characterized by intraepidermal blistering and skin fragility caused by mutations in the keratin (KRT) 5 or 14 genes. Despite a vast knowledge about the intermediate filament pathology in this disease, the progress in therapy has been slow. Animal models and well-characterized continuous cell culture models of EBS are needed prior to clinical testing. OBJECTIVES: Our aim was to generate immortalized cell lines as an in vitro model for the study of EBS and test a chemical chaperone, trimethylamine N-oxide (TMAO), as a putative novel therapy. METHODS: We generated four immortalized cell lines, two each from an EBS patient with a KRT5-mutation (V186L) and a healthy control, using human papillomavirus 16 (HPV16) E6E7 as transducer. Cell lines were established in serum-free and serum-containing medium and assessed for growth characteristics, keratin expression profiles, ability to differentiate in organotypic cultures, and response to heat stress with and without the presence of TMAO. RESULTS: All cell lines have been expanded >160 population doublings and their cellular characteristics are similar. However, the formation of cytoplasmic keratin filament aggregates in response to heat-shock treatment differed between EBS and normal cell lines. Notably, serum-free established EBS-cell line was most vulnerable to heat shock but both cell lines exhibited significant reduction in the number of keratin aggregates containing cells by TMAO. CONCLUSION: The immortalized cell lines represent a suitable model for studying novel therapies for EBS. TMAO is a promising new agent for future development as a novel EBS therapy.

Keyword

Chemical chaperone
Cytoprotection
EBS-cell lines
Genetic skin disorder
Human papilloma virus 16 E6/E7
Heat stress
Keratin
Organotypic epidermis
TMAO
MEDICINE
MEDICIN
Dermatology and Venerology
Dermatologi och venereologi

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view